![]() |
市場調查報告書
商品編碼
1930091
全球心血管保健品市場:市場規模、佔有率、成長率、產業分析、依類型、應用和地區劃分的考量、未來預測(2026-2034)Cardiovascular Health Supplements Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034 |
||||||
由於人們對心臟健康的日益關注以及心血管疾病在全球範圍內的患病率不斷上升,全球心血管保健品市場正經歷著穩步增長。 根據 Fortune Business Insights 預測,2025 年市場規模預計將達到 123.1 億美元,2026 年將成長至 130 億美元。在預測期內,預計到 2034 年,市場規模將達到 215.1 億美元,2026 年至 2034 年的複合年增長率 (CAGR) 為 6.50%。
北美地區引領心血管健康補充品市場,預計到 2025 年將佔 40.98% 的市場佔有率,這主要得益於人們健康意識的提高、預防醫學的普及以及人口老化。
市場概覽
心血管健康補充劑透過幫助控制膽固醇水平、血壓和整體血管健康來支持心臟功能。 這些補充劑包括omega-3脂肪酸、魚油、紅麴、輔酶Q10 (CoQ10)、膳食纖維、固醇、亞麻仁油和各種草藥萃取物。肥胖、不良飲食和缺乏運動等生活方式相關疾病的增加,顯著提高了心臟病的風險,從而推動了對預防性營養解決方案的需求。
此外,老年人越來越關注心臟健康,他們希望透過高品質的傳統和天然補充劑來降低心血管疾病併發症的風險,這也推動了市場的發展。
新冠疫情的影響
新冠疫情對心血管健康補充劑市場產生了正面影響。人們對免疫力和心臟健康的關注度提高,促使補充劑的消費量增加。疫情期間,由於心臟健康補充劑的需求增加,主要生產商的收入也實現了成長。即使在疫情結束後,由於人們對預防醫學的持續關注,該市場仍保持著穩定成長。 保健品生產商加大廣告和促銷力度,也進一步推動了市場擴張。
市場趨勢
消費者越來越傾向選擇天然成分
最顯著的趨勢之一是消費者越來越偏好天然來源的心血管保健品。由於擔心合成營養素的副作用,消費者越來越多地選擇成分純淨、植物性和草本產品。天然保健品被認為較安全,適合長期服用,並有益於改善血液循環、提升精力水平和增強心臟功能。這種轉變促使生產商推出採用天然配方的創新產品。
市場成長驅動因素
心血管疾病發生率上升
心血管疾病(包括心律不整、冠狀動脈疾病、高血壓和中風)發生率的上升是市場成長的主要驅動因素。久坐不動的生活方式和不健康的飲食習慣加劇了已開發國家和發展中國家心臟病負擔的加重。 作為一項預防措施,每日服用心血管保健品的人數正在增加。
產品上市數量不斷增加
隨著膳食補充劑消費量的增長,老牌企業和新晉企業都在積極推出創新的心血管健康產品。製造商正在開發各種劑型的補充劑,包括膠囊、片劑和軟糖,以涵蓋更廣泛的消費群。這種產品創新和供應量的增加正在推動市場成長。
限制因子
仿冒品的流通
儘管市場成長強勁,但假冒和貼錯標籤的補充劑流通日益增多,給市場帶來了挑戰。消費者無法區分正品和仿冒品,限制了它們的普及。監管機構對貼錯標籤的心臟健康補充劑的警告凸顯了加強品質控制和消費者教育的必要性。
依類型
市場依類型分為天然補充劑和合成補充劑。
預計到2026年,天然補充劑將佔市場主導地位,市佔率達60.63%,主要得益於消費者對植物來源和草藥成分的偏好。合成補充劑也佔了相當大的市場佔有率,這主要歸功於其成本效益和臨床研究的支持。
依成分
預計到2026年,維生素和礦物質將佔42.23%的市場佔有率,這主要得益於它們在維持血壓、減輕發炎和改善血管功能方面的作用。其他成分,例如草藥萃取物、ω-3脂肪酸和輔酶Q10,也越來越受到關注。
依劑型劃分
由於膠囊劑型服用方便、吸收迅速且劑量選擇多樣,預計到2026年,膠囊劑型將以51.90%的市佔率領先市場。片劑和軟糖產品的市場接受度也在不斷提高。
依通路劃分
由於購買便利且消費者信任度高,藥局和零售藥局仍佔分銷主導地位。線上藥局預計將因其便利性和電子商務滲透率的不斷提高而穩步增長。
預計到2025年,北美地區的市場收入將達到50.5億美元,憑藉較高的市場認知度和強大的製造商實力,將繼續保持領先地位。歐洲地區將佔較大佔有率,這主要得益於消費者對植物補充劑的需求不斷增長。亞太地區將受益於心血管疾病盛行率的上升和預防保健理念的日益普及,以實現快速成長。
The global cardiovascular health supplements market is witnessing steady growth due to rising awareness about heart health and the increasing prevalence of cardiovascular diseases worldwide. According to Fortune Business Insights, the market was valued at USD 12.31 billion in 2025 and is projected to grow to USD 13.0 billion in 2026. Over the forecast period, the market is expected to reach USD 21.51 billion by 2034, registering a CAGR of 6.50% from 2026 to 2034.
North America dominated the cardiovascular health supplements market with a 40.98% share in 2025, supported by high health awareness, strong preventive healthcare adoption, and a growing aging population.
Market Overview
Cardiovascular health supplements support heart function by helping manage cholesterol levels, blood pressure, and overall vascular health. These supplements include omega-3 fatty acids, fish oil, red yeast rice, Coenzyme Q10 (CoQ10), fiber, sterols, flaxseed oil, and various herbal extracts. Growing lifestyle-related health issues such as obesity, poor diet, and sedentary behavior have significantly increased the risk of heart disease, driving demand for preventive nutritional solutions.
The market is also benefiting from the rising focus of elderly populations on maintaining heart health through high-quality conventional and natural supplements, reducing the risk of complications related to cardiovascular diseases.
Impact of COVID-19
The COVID-19 pandemic had a positive impact on the cardiovascular health supplements market. Increased focus on immunity and heart health led to higher consumption of supplements. During the pandemic, key manufacturers experienced revenue growth due to rising adoption of heart health supplements. Post-pandemic, the market continues to grow steadily as awareness of preventive healthcare remains strong. Increased advertising and promotional campaigns by supplement manufacturers further support market expansion.
Market Trends
Increasing Shift Toward Natural Ingredients
One of the most prominent trends is the growing preference for natural cardiovascular health supplements. Consumers are increasingly choosing products with clean-label, plant-based, and herbal ingredients due to concerns about the side effects of synthetic nutrients. Natural supplements are perceived as safer for long-term consumption and beneficial for improving blood circulation, energy levels, and heart function. This shift is encouraging manufacturers to launch innovative products with natural formulations.
Market Growth Drivers
Rising Prevalence of Cardiovascular Diseases
The increasing incidence of cardiovascular conditions such as arrhythmia, coronary artery disease, hypertension, and stroke is a major driver of market growth. Sedentary lifestyles and unhealthy dietary habits are contributing to a rising burden of heart disease across both developed and developing regions. As a preventive approach, a growing number of individuals are incorporating cardiovascular supplements into their daily routines.
Increasing Product Launches
The growing consumption of dietary supplements has encouraged both established and new players to introduce innovative cardiovascular health products. Manufacturers are developing supplements in various dosage forms such as capsules, tablets, and gummies to attract a broader consumer base. This rising product innovation and availability are accelerating market growth.
Restraining Factors
Availability of Counterfeit Products
Despite strong growth, the market faces challenges from the increasing availability of counterfeit and misbranded supplements. The inability of consumers to distinguish between approved products and unauthorized supplements limits adoption. Regulatory warnings issued against misbranded heart health supplements highlight the need for stricter quality control and consumer education.
By Type
Based on type, the market is segmented into natural supplements and synthetic supplements.
The natural supplements segment dominated with a 60.63% share in 2026, driven by consumer preference for plant-based and herbal ingredients. The synthetic supplements segment also holds a notable share due to their cost-effectiveness and clinical research support.
By Ingredients
The vitamins & minerals segment dominated with a 42.23% market share in 2026, supported by their role in maintaining blood pressure, reducing inflammation, and improving vascular function. Herbal extracts and other ingredients such as omega-3 fatty acids and CoQ10 are also gaining traction.
By Dosage Form
The capsules segment led the market with a 51.90% share in 2026, owing to ease of consumption, quick absorption, and availability in multiple dosages. Tablets and gummies are also witnessing increasing adoption.
By Distribution Channel
Drug stores and retail pharmacies dominate distribution due to easy accessibility and consumer trust. Online pharmacies are expected to grow steadily due to convenience and expanding e-commerce penetration.
North America generated USD 5.05 billion in revenue in 2025, maintaining its leading position due to high awareness and strong manufacturer presence. Europe holds a significant share due to rising demand for plant-based supplements. Asia Pacific is witnessing rapid growth driven by increasing cardiovascular disease prevalence and growing acceptance of preventive healthcare.
Competitive Landscape
The market is fragmented, with key players including Amway, Thorne, Herbalife, Swisse Wellness, Gaia Herbs, and NOW FOODS. Companies are focusing on certifications, collaborations, and innovative product launches to strengthen their market position.
Conclusion
The global cardiovascular health supplements market, valued at USD 12.31 billion in 2025, is projected to reach USD 13.0 billion in 2026 and USD 21.51 billion by 2034. Rising cardiovascular disease prevalence, increasing preference for natural supplements, and continuous product innovation are expected to support market growth during the forecast period.
Segmentation
By Type
By Ingredients
By Dosage Form
By Distribution Channel
By Region